WellSpan Health and Johns Hopkins Medicine have renewed a cancer-care partnership designed to bring big-center expertise to patients in central Pennsylvania without requiring them to travel far from home.
The collaboration provides physician consultations, multidisciplinary tumor conferences, access to expertise across 12 cancer subspecialties, and enrollment in Johns Hopkins clinical trials — serving the Central Susquehanna Valley and York County. Over the past five years it has served more than 1,300 patients, with about 500 enrolled in Johns Hopkins clinical trials.
What’s new
Beginning in autumn 2026, WellSpan Evangelical Community Hospital will roll out phased additions including local oncology, infusion services, radiation oncology and advanced cancer services. The partnership dates to 2017 and was previously expanded in 2021.
Why it matters
Access to leading cancer care — and to clinical trials — is often concentrated in major urban centers, leaving rural and smaller-community patients underserved. “Every patient deserves access to the highest level of cancer expertise, regardless of where they live,” said Johns Hopkins’ Kevin Sowers. WellSpan CEO Roxanna Gapstur said the renewal reflects “our shared commitment to ensure more people can access world-class cancer care.”